Clinical trial
Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer
NCT00298064 · University of New Mexico, Other · Withdrawn
Key facts
| NCT number | NCT00298064 |
|---|---|
| Title | Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer |
| Official title | Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer |
| Lead sponsor | University of New Mexico, Other |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Cervical Cancer, Cervix |
| Intervention type | Genetic |
| Interventions | Tissue Repository |
| Enrollment | 0 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Mar 1, 2006 |
| Last update posted | Jul 5, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: